News

Ionis Pharmaceuticals, Inc. announced the closing of the collaboration agreement with AstraZeneca to develop and commercialize eplontersen, Ionis' investigational antisense medicine for…
Read More...

Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has tentatively approved the Company's Abbreviated New Drug Application for Vasopressin injection,…
Read More...

Ascletis Pharma Inc. announces the expansion of the production of ritonavir oral tablets and oral direct-acting antiviral R&D pipeline for the treatment of SARS-CoV-2 infection. The…
Read More...

Merck known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization…
Read More...

Evotec SE announced that the Company has received a US$ 18 m grant from the Bill & Melinda Gates Foundation (Seattle, WA, USA, “the foundation”) for the integrated discovery and…
Read More...

SAB Biotherapeutics, a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies…
Read More...

BioMarin Pharmaceutical Inc. and Skyline Therapeutics (formerly Geneception), a gene and cell therapy company focused on developing novel treatments for unmet medical needs, announced a…
Read More...

Valneva SE a specialty vaccine company, today announced positive homologous booster data from the Phase 1/2 study, of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001.…
Read More...

Navidea Biopharmaceuticals, Inc., a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, announced the launch of the NAV3-33 Phase 3 clinical…
Read More...

Pfizer Inc. announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued advice on the use of PAXLOVID (nirmatrelvir tablets…
Read More...

Alpine Immune Sciences, Inc. and Horizon Therapeutics plc announced an exclusive license and collaboration agreement for the development and commercialization of up to four preclinical…
Read More...

Merck, known as MSD outside the United States and Canada, announced the European Commission (EC) has approved VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) for active…
Read More...

Boehringer Ingelheim announced that the U.S. Food and Drug Administration (FDA) has accepted a Biologics License Application (BLA) and granted Priority Review for spesolimab for the…
Read More...

Rakuten Medical, Inc announced that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug (IND) application to begin clinical studies of…
Read More...

Immatics N.V. a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, and Bristol Myers Squibb announced that…
Read More...

Zealand Pharma A/S a biotechnology company focused on the discovery, development and commercialization of innovative peptide-based medicines, announced a financing agreement with…
Read More...

Atea Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, today announced an updated strategy for AT-527 to address the rapidly evolving SARS-CoV-2 and emerging variants by…
Read More...

Pfizer Inc. announced final results from an analysis of all 2,246 adults enrolled in its Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) trial…
Read More...

Biogen Inc. and TheraPanacea announced that they have entered into a collaboration focused on multiple therapeutic areas in neuroscience, to further build on the companies’ existing…
Read More...

Merck, a leading science and technology company, announced that it has signed an agreement with biotechnology company Innovative Biotech (IB) to design the manufacturing process for the…
Read More...